L&K Biomed Ltd. (KOSDAQ:156100)

Market Cap	106.73B -44.6%
Revenue (ttm)	39.94B -0.1%
Net Income	2.77B +36.5%
EPS	128.57 +45.1%
Shares Out	22.35M
PE Ratio	37.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	248,531
Open	5,000.00
Previous Close	4,980.00
Day's Range	4,700.00 - 5,050.00
52-Week Range	2,730.00 - 16,400.00
Beta	0.61
Analysts	n/a
Price Target	n/a
Est. Earnings	Mar 12, 2027

About L&K Biomed

L&K Biomed Ltd., engages in the manufacturing, production, and sales of medical devices in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable A...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2008
• Employees: 105
• Stock Exchange: KOSDAQ
• Ticker Symbol: 156100

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 13, 2026

Data Sources Report a data error